¼¼°è ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Pyrogen Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå
:
1478024
¸®¼Ä¡»ç
:
Persistence Market Research
¹ßÇàÀÏ
:
2024³â 05¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 444 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» ¹ßÇ¥ÇßÀ¸¸ç, ÁÖ¿ä ½ÃÀå ¿ªÇÐ, ¼ºÀå ÃËÁø¿äÀÎ ¹× °úÁ¦, ½ÅÈï µ¿ÇâÀÇ Á¾ÇÕÀûÀÎ °³¿ä¸¦ Á¦°øÇß½À´Ï´Ù. º» º¸°í¼´Â 2024³âºÎÅÍ 2031³â±îÁö ½ÃÀåÀÇ ¼ºÀå ±Ëµµ¸¦ ¿¹ÃøÇÏ´Â µ¶Á¡ µ¥ÀÌÅÍ¿Í Åë°è¸¦ Á¦½ÃÇϰí, ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡ ´ëÇÑ ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀåÀº 2024³â¿¡ 20¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, ÇâÈÄ 10³â°£Àº CAGR 12.2%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø¿¡¼ ½ÃÀå ¼öÀÍÀº 2031³â±îÁö 45¾ï 6,000¸¸ ´Þ·¯·Î ±ÞÁõÇÏ¿© ½ÃÀåÀÇ ´ëÆøÀûÀÌ°í ±àÁ¤ÀûÀÎ È®´ë¸¦ º¸¿©ÁÝ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ±Ô¸ð(2024³â) : 20¾ï 4,000¸¸ ´Þ·¯
½ÃÀå ¿¹Ãø ±Ý¾×(2031³â) : 45¾ï 6,000¸¸ ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(2024-2031³â) : CAGR12.2%
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå - º¸°í ¹üÀ§:
ÆÄÀÌ·ÎÁ¨ Å×½ºÆ®´Â ÀǾàǰ ¹× ÀÇ·á±â±â Á¦Á¶ÀÇ Áß¿äÇÑ Ãø¸éÀ¸·Î ÀÛ¿ëÇϸç, ÆÄÀÌ·ÎÁ¨ ¿À¿°À» °¨ÁöÇÏ¿© Á¦Ç°ÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» º¸ÀåÇÕ´Ï´Ù. º» º¸°í¼´Â ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ä¿ëÀ» ÃËÁøÇÏ´Â ´Ù¾çÇÑ ¿ëµµ°ú ±â¼úÀû Áøº¸¸¦ Á¶»çÇß½À´Ï´Ù.
¸î °¡Áö ¿äÀÎÀÌ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ȯÀÚÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ °ü½É Áõ°¡, ÆÄÀÌ·ÎÁ¨ ¿À¿° »ç°í Áõ°¡ µîÀÌ ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ½ÃÇè°ü¹ý°ú ÀÚµ¿È ½Ã½ºÅÛÀÇ Ã¤¿ë µî, °Ë»ç ¹æ¹ýÀÇ Áøº¸°¡ °Ë»ç Á¤¹Ðµµ¿Í È¿À²À» ³ô¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀåÀº ÆÄÀÌ·ÎÁ¨ ¿À¿° °Ë»ç¸¦ Àǹ«ÈÇÏ´Â ÀǾàǰ¡¤ÀÇ·á±â±â Á¦Á¶¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ »óȲÀ¸·ÎºÎÅÍ ÀÌÀÍÀ» ¾ò°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Á¦Ç°ÀÇ ¾ÈÀü¼º°ú ÄÄÇöóÀ̾𽺸¦ º¸ÀåÇϱâ À§ÇÑ ÆÄÀÌ·ÎÁ¨ ½ÃÇèÀÇ Á߿伺¿¡ ´ëÇÑ Á¦Á¶¾÷üÀÇ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ö¿ä°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å¼ÓÇϰí ÀÚµ¿ÈµÈ °Ë»ç ½Ã½ºÅÛÀÇ µµÀÔ°ú °°Àº °Ë»ç ±â¹ýÀÇ ±â¼úÀû Áøº¸´Â °Ë»ç ÇÁ·Î¼¼½º¸¦ °£¼ÒÈÇÏ°í ³³±â¸¦ ´ÜÃàÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
¼ºÀåÀÌ ¿¹»óµÇÁö¸¸, ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡´Â °úÁ¦µµ Á¸ÀçÇÕ´Ï´Ù. °Ë»ç ÀýÂ÷ ¹× Àåºñ¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀº Áß¼Ò±â¾÷ ½ÃÀå ÁøÀÔ À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °Ë»ç ±â¹ýÀÇ º¹À⼺°ú Àü¹® Áö½ÄÀÇ Çʿ伺 ¶§¹®¿¡ ƯÈ÷ ½ÅÈï±¹¿¡¼´Â ä¿ë·üÀÌ Á¦ÇѵǾî ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯Á¤ °Ë»ç ¹æ¹ýÀÇ Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á°¡ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖÀ¸¸ç ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀÌ ÇÊ¿äÇÕ´Ï´Ù.
½ÃÀå ±âȸ:
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡´Â ±â¼ú Çõ½Å°ú È®ÀåÀÇ Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. °Ë»ç ¹æ¹ýÀÇ °³¼±, °¨µµ¿Í ƯÀ̼ºÀÇ Çâ»ó, °Ë»ç ºñ¿ëÀÇ »è°¨À» ¸ñÇ¥·Î ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀº »õ·Î¿î ½ÃÀå °³Ã´ÀÇ ¿¼è°¡ µË´Ï´Ù. ¶ÇÇÑ ·Îº¿ °øÇаú ÀΰøÁö´É°ú °°Àº ÷´Ü ±â¼úÀ» °Ë»ç ½Ã½ºÅÛ¿¡ ÅëÇÕÇÔÀ¸·Î½á °øÁ¤À» ´õ¿í °£¼ÒÈÇϰí È¿À²¼ºÀ» ³ôÀÏ ¼ö ÀÖÀ¸¸ç ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ´Â »ê¾÷°ú ¿ëµµ´Â?
±â¼ú Áøº¸´Â ¾î¶»°Ô ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå °æÀï ±¸µµ¸¦ ¹Ù²Ù°í Àִ°¡?
¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡¼ ÁÖ¿ä ±â¾÷Àº?
¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡´Â ¾î¶² ½ÅÈï µ¿Çâ°ú ¹Ì·¡ Àü¸ÁÀÌ ¿¹ÃøµÇ´Â°¡?
°æÀï Á¤º¸ ¹× ºñÁî´Ï½º Àü·«:
ÆÄÀÌ·ÎÁ¨ Å×½ºÆ® ÀåºñÀÇ ¿µ¿ª¿¡¼ Á¦Á¶¾÷ü´Â ½ÃÀå¿¡¼ÀÇ Á¸Àç°¨À» ³ôÀ̱â À§ÇØ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, Á¦Ç° Ãâ½Ã ¹× Àμö¿¡ Àü·«ÀûÀ¸·Î ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Eurofins'°¡ 2022³â 1¿ù¿¡ PFAS ·¹º§À» ÃøÁ¤ÇÏ´Â ÃÖÃÊÀÇ °¡Á¤¿ë °Ë»çÀÎ PFAS Exposure(TM)¸¦ ¹ßÇ¥ÇÑ °ÍÀº ƯÇÊÇØ¾ß ÇÒ Áøº¸ÀÔ´Ï´Ù. ¸¶Âù°¡Áö·Î Associates of Cape Cod, Inc.(ACC)´Â 2021³â 4¿ù ¹ÚÅ׸®¾Æ¼º ³»µ¶¼Ò °Ë»ç(BET)¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ÀçÁ¶ÇÕ LAL ½Ã¾àÀÎ PyroSmart NextGen(TM)À» ¹ßÇ¥Çß½À´Ï´Ù. Lonza°¡ 2020³â 10¿ù¿¡ Ãâ½ÃÇÑ ÆÄÀ̷μ¿ ´ÜÇÙ±¸ Ȱ¼ºÈ °Ë»ç ½Ã½ºÅÛÀº SanquinÀÇ ÃÖÀûÈµÈ MAT ½Ã¾à°ú LonzaÀÇ ¹èÁö ¹× ¾×¼¼¼¸®¸¦ °áÇÕÇÑ Á¾ÇÕÀûÀÎ ½ÃÇè°ü ³» ÆÄÀÌ·ÎÁ¨ Å×½ºÆ® ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Persistence Market Research´Â ÆÄÀÌ·ÎÁ¨ ½ÃÇè ºÐ¾ßÀÇ ÀÌ·¯ÇÑ ½ÃÀå °³Ã´À» ¿½ÉÈ÷ ÃßÀûÇϰí Á¾ÇÕÀûÀÎ º¸°í¼¿¡¼ »ó¼¼ÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
Thermo Fisher Scientific
Merck KGaA
Lonza
MAT-BioTech
Promega Corporation
GenScript
Associates of Cape Cod, Inc.
BIOMERIEUX SA
Ella A/S
Hycult Biotech Inc.
Eurofins Biolab Srl
Solvias AG
Wickham Laboratories Ltd.
Sotera Health(Nelson Laboratories, LLC)
Charles River Laboratories
Creative Biolabs
Sanquin Reagents BV
Fujifilm Wako Pure Chemical Corporation
MAT Research
Xiamen Bioendo Technology Co. Ltd.
Microcoat Biotechnologie GmbH
PerkinElmer Inc.
Orchid Scientific & Innovative Pvt Ltd.
ÆÄÀÌ·ÎÁ¨ Å×½ºÆ® ½ÃÀåÀÇ ¼¼ºÐÈ
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå : Á¦Ç° ¹× ¼ºñ½ºº°
µðÁöÅРü¿Â°è Àåºñ
ÀÚµ¿ ³»µ¶¼Ò °Ë»ç Àåºñ
ÈÞ´ë¿ë ¿£µµÅå½Å °Ë»ç Àåºñ
¸¶ÀÌÅ©·ÎÇ÷¹ÀÌÆ® ¸®´õ
À¯ÀüÀÚ ÀçÁ¶ÇÕ C ÀÎÀÚ ÃøÁ¤ ¹æ¹ý
¸®¹«·ç½º ¾Æ¸Þ¹Ù »çÀÌÅ»¸®¾Æ¼¼ÀÌÆ®(LAL) Å×½ºÆ®
¹ß»ö½ÃÇè
ʵµ ÃøÁ¤
°ÖÅ©·ÎÆ®½ÃÇè
Åä³¢ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè
´Ü±¸ Ȱ¼º ÃøÁ¤¹ý
³»µ¶¼Ò Å×½ºÆ® ¼ºñ½º
´Ü±¸ Ȱ¼ºÈ ½ÃÇè ¼ºñ½º
°ø±Þ¿øº° ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
ü¿Ü ±â¹ÝÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè
ÀüÇ÷ ´Ü±¸
¸»ÃÊ Ç÷¾× ´ÜÇÙ±¸(PBMC) ±â¹Ý ´ÜÇÙ±¸
¼¼Æ÷ÁÖ ±â¹Ý ´ÜÇÙ±¸
µ¿¹° ±â¹ÝÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè
ÀçÁ¶ÇÕ ¿äÀÎ(rFC)
¼¼±Õ¼º ³»µ¶¼Ò(BET)
Åä³¢ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè
¿ëµµº° ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
ÁÖ»ç¿ë Ä¡·áÁ¦
¹é½Å
°æ±¸ Åõ¿© ÀǾàǰ
»ý¹°Á¦Á¦
À̽ÄÇü ÀÇ·á±â±â
Åõ¼®¾×
µ¶¼º/¸é¿ªÁ¶ÀýÁ¦
Ç÷¾× ±â¹Ý Á¦Ç°
ÆÄÀÌ·ÎÁ¨ Å×½ºÆ® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
Á¦¾àȸ»ç
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
ÀÇ·á±â±â ±â¾÷
Áø´Ü ½ÇÇè½Ç
Àӻ󿬱¸±â°ü(CRO)
ÀÓ»óÁ¦Á¶±â°ü(CMO)
ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå : Áö¿ªº°
ºÏ¹ÌÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
À¯·´ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
³²¾Æ½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
µ¿¾Æ½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
¿À¼¼¾Æ´Ï¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/ ¹üÀ§/ Á¦ÇÑ
Æ÷ÇÔ »çÇס¤ Á¦¿Ü »çÇ×
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä µ¿Çâ
Á¦Ç° Çõ½Å/ °³¹ß µ¿Çâ
Á¦4Àå ÁÖ¿ä ¼º°ø ¿äÀÎ
ÀÓ»ó½ÃÇè ºÐ¼®
¾ð¸ä ¿ä±¸
±ÔÁ¦ ½Ã³ª¸®¿À
¹ß¿ ¹°Áú ¹× ¿£µµÅå½ÅÀÇ °ËÃâ ¹æ¹ý
½Ç½ÃÇÑ ½ÃÇèÀÇ ÃßÁ¤¼ö
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID19 À§±â ºÐ¼®
COVID-19ÀÇ ÇöÀç Åë°è¿Í ¹Ì·¡ÀÇ ¿µÇâ °¡´É¼º
2008³â°ú ºñ±³ÇÑ ÇöÀçÀÇ °æÁ¦ ¿¹Ãø °æÁ¦ ºÐ¼®
COVID-19°¡ ÇコÄÉ¾î ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ
COVID-19°¡ ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
Á¦7Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ¼ö¿ä, ¼ö·® ºÐ¼®
°ú°Å ½ÃÀå ¼ö·® ºÐ¼®(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ¼ö·® ¿¹Ãø(2024-2031³â)
Á¦8Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå - °¡°Ý ºÐ¼®
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°Ý ºÐ¼® : Áö¿ªº°
°¡°Ý ¼³Á¤ÀÇ ÀüÁ¦Á¶°Ç
Á¦9Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ¼ö¿ä ºÐ¼®
°ú°Å ½ÃÀå ¸ÅÃ⠺м®(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ¸ÅÃâ ¿¹Ãø(2024-2031³â)
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë¾×ÀÇ ±âȸ ºÐ¼®
Á¦10Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼ºñ½ºº°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼® : Á¦Ç° ¹× ¼ºñ½ºº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø : Á¦Ç° ¹× ¼ºñ½ºº°(2024-2031³â)
±â±â
Å×½ºÆ® ŰƮ ¹× ½Ã¾à
¼Ò¸ðǰ
¼ºñ½º
½ÃÀå ¸Å·Âµµ ºÐ¼® : Á¦Ç° ¹× ¼ºñ½ºº°
Á¦11Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼® : À¯·¡º°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, : À¯·¡º°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø : À¯·¡º°(2024-2031³â)
In-vitro º£À̽º
µ¿¹° º£À̽º
½ÃÀå ¸Å·Âµµ ºÐ¼® : À¯·¡º°
Á¦12Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼® : ¿ëµµº°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ¿ëµµº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°(2024-2031³â)
ÁÖ»çÁ¦
¹é½Å
°æ±¸ Åõ¿© ÀǾàǰ
»ý¹°ÇÐÀû Á¦Çü
À̽ÄÇü ÀÇ·á±â±â
Åõ¼®¾×
µ¶¼º/¸é¿ªÁ¶ÀýÁ¦
Ç÷¾× À¯·¡ Á¦Ç°
½ÃÀå ¸Å·Âµµ ºÐ¼® : ¿ëµµº°
Á¦13Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
¼Ò°³/ ÁÖ¿ä Á¶»ç °á°ú
°ú°Å ½ÃÀå ±Ô¸ð ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°(2019-2023³â)
ÇöÀç ¹× ¹Ì·¡ ½ÃÀå ±Ô¸ðÀÇ ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(2024-2031³â)
Á¦¾àȸ»ç
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
ÀÇ·á±â±â ±â¾÷
Áø´Ü ½ÇÇè½Ç
ÀÓ»óÁ¶»ç±â°ü(CRO)
ÀÓ»óÁ¦Á¶Á¶Á÷(CMO)
½ÃÀå ¸Å·Âµµ ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°
Á¦14Àå ¼¼°èÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼® : Áö¿ªº°
¼Ò°³
°ú°Å ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼® : Áö¿ªº°(2019-2023³â)
ÇöÀç ½ÃÀå ±Ô¸ð¿Í ¼ö·® ºÐ¼®°ú ¿¹Ãø :Áö¿ªº°(2024-2031³â)
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(MEA)
½ÃÀå ¸Å·Âµµ ºÐ¼® :Áö¿ªº°
Á¦15Àå ºÏ¹ÌÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦16Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦17Àå À¯·´ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦18Àå ³²¾Æ½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦19Àå µ¿¾Æ½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦20Àå ¿À¼¼¾Æ´Ï¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦21Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦22Àå ±¹°¡º° ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®(2024-2031³â)
¼Ò°³
¹Ì±¹ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ij³ª´ÙÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
¸ß½ÃÄÚÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ºê¶óÁúÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
µ¶ÀÏÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ÀÌÅ»¸®¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ÇÁ¶û½ºÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
¿µ±¹ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
½ºÆäÀÎÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
·¯½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
º£³×·è½ºÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Áß±¹ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ÀϺ»ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Çѱ¹ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ÀεµÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ű¹ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
È£ÁÖÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
´ºÁú·£µåÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
GCC ±¹°¡ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
ÅÍŰÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
³²¾ÆÇÁ¸®Ä«ÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Àεµ³×½Ã¾ÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
¸»·¹À̽þÆÀÇ ÆÄÀÌ·ÎÁ¨ ½ÃÇè ½ÃÀå ºÐ¼®
Á¦23Àå ½ÃÀå ±¸Á¶ ºÐ¼®
½ÃÀå ºÐ¼® : ±â¾÷ °èÃþº°
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀåÇöÀçºÐ¼®
Á¦24Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼ Á¤º¸
Thermo Fisher Scientific
Merck KGaA
Lonza
MAT-BioTech
Promega Corporation
GenScript
Associates of Cape Cod, Inc.
BIOMERIEUX SA
Ella A/S
Hycult Biotech Inc.
Eurofins Biolab Srl
Solvias AG
Wickham Laboratories Ltd.
Sotera Health(Nelson Laboratories, LLC)
Charles River Laboratories
Creative Biolabs
Sanquin Reagents BV
Fujifilm Wako Pure Chemical Corporation
MAT Research
Xiamen Bioendo Technology Co. Ltd.
Microcoat Biotechnologie GmbH
PerkinElmer Inc.
Orchid Scientific & Innovative Pvt Ltd.
Á¦25Àå ÀüÁ¦Á¶°Ç°ú »ç¿ëµÇ´Â ¾à¾î
Á¦26Àå Á¶»ç ¹æ¹ý
JHS
¿µ¹® ¸ñÂ÷
Persistence Market Research has recently published an in-depth analysis of the global Pyrogen Testing Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Pyrogen Testing Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2024 to 2031.
The global pyrogen testing market reached US$ 2.04 billion in 2024 and is expected to grow at a CAGR of 12.2% over the next decade. Projections suggest that market revenue will soar to US$ 4.56 billion by 2031, indicating significant and positive market expansion.
Key Insights:
Pyrogen Testing Market Size (2024) - US$ 2.04 Bn
Projected Market Value (2031) - US$ 4.56 Bn
Global Market Growth Rate (2024-2031) - 12.2% CAGR
Pyrogen Testing Market - Report Scope:
Pyrogen testing serves as a critical aspect of pharmaceutical and medical device manufacturing, ensuring the safety and efficacy of products by detecting pyrogen contamination. This report explores the diverse applications and technological advancements driving the adoption of pyrogen testing globally.
Several factors drive the growth of the pyrogen testing market. Stringent regulatory requirements, increasing focus on patient safety, and rising incidences of pyrogen contamination incidents propel market expansion. Additionally, advancements in testing methodologies, such as the adoption of in vitro methods and automated systems, enhance testing accuracy and efficiency, further stimulating market growth.
Market Growth Drivers:
The pyrogen testing market benefits from the stringent regulatory landscape governing pharmaceutical and medical device manufacturing, which mandates the testing of products for pyrogen contamination. Additionally, increasing awareness among manufacturers regarding the importance of pyrogen testing in ensuring product safety and compliance drives market demand. Moreover, technological advancements in testing methodologies, such as the introduction of rapid and automated testing systems, streamline testing processes and reduce turnaround time, fostering market growth.
Market Restraints:
Despite growth prospects, challenges exist in the pyrogen testing market. High costs associated with testing procedures and equipment pose barriers to market entry for small and medium-sized enterprises. Furthermore, the complexity of testing methodologies and the need for specialized expertise limit adoption rates, particularly in emerging economies. Moreover, concerns regarding the accuracy and reliability of certain testing methods may impede market growth, necessitating ongoing research and development efforts to address these challenges.
Market Opportunities:
The pyrogen testing market presents significant opportunities for innovation and expansion. Continued research and development aimed at improving testing methodologies, enhancing sensitivity and specificity, and reducing testing costs are key to unlocking new market avenues. Additionally, the integration of advanced technologies such as robotics and artificial intelligence into testing systems can further streamline processes and improve efficiency, driving market growth.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the Pyrogen Testing Market?
Which industries and applications are driving the demand for Pyrogen Testing?
How are technological advancements reshaping the competitive landscape of the Pyrogen Testing Market?
Who are the leading players in the global Pyrogen Testing Market?
What emerging trends and future prospects are anticipated in the global Pyrogen Testing Market?
Competitive Intelligence and Business Strategy:
In the realm of pyrogen testing devices, manufacturers are strategically focusing on regulatory approvals, product launches, and acquisitions to bolster their market presence. Eurofins' introduction of PFAS Exposure(TM) in January 2022, the first at-home test for measuring PFAS levels, is a notable advancement. Similarly, Associates of Cape Cod, Inc. (ACC) unveiled PyroSmart NextGen(TM) in April 2021, an innovative recombinant LAL reagent for Bacterial Endotoxin Testing (BET). Lonza's October 2020 launch of the Pyro Cell Monocyte Activation Test System provides a comprehensive in-vitro pyrogen testing solution, combining optimized MAT reagents from Sanquin with Lonza's media and accessories. Persistence Market Research diligently tracks such developments in the pyrogen testing sector, offering detailed insights in their comprehensive report.
Key Companies Profiled:
Thermo Fisher Scientific
Merck KGaA
Lonza
MAT-BioTech
Promega Corporation
GenScript
Associates of Cape Cod, Inc.
BIOMERIEUX SA
Ella A/S
Hycult Biotech Inc.
Eurofins Biolab Srl
Solvias AG
Wickham Laboratories Ltd.
Sotera Health (Nelson Laboratories, LLC)
Charles River Laboratories
Creative Biolabs
Sanquin Reagents B.V.
Fujifilm Wako Pure Chemical Corporation
MAT Research
Xiamen Bioendo Technology Co. Ltd.
Microcoat Biotechnologie GmbH
PerkinElmer Inc.
Orchid Scientific & Innovative Pvt Ltd.
Pyrogen Testing Market Segmentation
Pyrogen Testing Market by Product & Service:
Digital Tele Thermometers Equipment
Automated Endotoxin Testing Equipment
Portable Endotoxin Testing Equipment
Microplate Readers
Recombinant Factor C Assays
Limulus Amebocyte Lysate (LAL) Tests
Chromogenic Tests
Turbid metric Tests
Gel-Clot Tests
Rabbit Pyrogen Tests
Monocyte Activity Assays
Endotoxin Testing Services
Monocyte Activation Testing Services
Pyrogen Testing Market by Source:
In-vitro-based Pyrogen Testing
Whole Blood-based Monocytes
Peripheral Blood Mononuclear Cell (PBMC)-based Monocytes
Cell Line-based Monocytes
Animal-based Pyrogen Testing
Recombinant Factor (rFC )
Bacterial Endotoxins (BET)
Rabbit Pyrogen Tests
Pyrogen Testing Market by Application:
Injectable Therapeutics
Vaccines
Orally-dosed Pharmaceuticals
Biologics
Implantable Medical Devices
Dialysis Liquids
Toxic/immune-modulatory Drugs
Blood-based Products
Pyrogen Testing Market by End User:
Pharmaceuticals Companies
Biotechnology Companies
Medical Device Companies
Diagnostic Laboratories
Clinical Research Organizations (CROs)
Clinical Manufacturing Organizations (CMOs)
Pyrogen Testing Market by Region:
North America Pyrogen Testing Market
Latin America Pyrogen Testing Market
Europe Pyrogen Testing Market
South Asia Pyrogen Testing Market
East Asia Pyrogen Testing Market
Oceania Pyrogen Testing Market
Middle East & Africa Pyrogen Testing Market
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Clinical Trial Analysis
4.2. Unmet Needs
4.3. Regulatory Scenario
4.4. Methods of Pyrogen and Endotoxin Detection
4.5. Estimated number of tests performed
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Expenditure
5.1.3. Global Life Science Market Outlook
5.1.4. Global Pyrogen Testing Market Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. Rising incidence of chronic diseases
5.2.3. Increased spending on pyrogen and endotoxin testing
5.2.4. Shift towards in-vitro testing
5.2.5. Adoption of alternative testing methods
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID 19 Statistics and Probable Future Impact
6.2. Current Economic Projection as compared to 2008 Economic analysis
6.3. Impact of COVID-19 on the healthcare industry.
6.4. Impact of COVID-19 on the global Pyrogen Testing market.
7. Global Pyrogen Testing Market Demand, in Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2031
7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (Units) Projections, 2024-2031
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Pyrogen Testing Market - Pricing Analysis
8.1. Global Average Pricing Analysis Benchmark
8.2. Price Analysis by Region.
8.3. Pricing Assumptions
9. Global Pyrogen Testing Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031
9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Products & Services
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) and Volume Analysis By Products & Services, 2019-2023
10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Products & Services, 2024-2031
10.3.1. Instruments
10.3.1.1. Digital Tele Thermometers Equipment
10.3.1.2. Automated Endotoxin Testing Equipment
10.3.1.3. Portable Endotoxin Testing Equipment
10.3.1.4. Microplate Readers
10.3.2. Test Kits & Reagents
10.3.2.1. Recombinant Factor C Assays
10.3.2.2. Limulus Amebocyte Lysate (LAL) Tests
10.3.2.2.1. Chromogenic Tests
10.3.2.2.2. Turbidimetric Tests
10.3.2.2.3. Gel-Clot Tests
10.3.2.3. Rabbit Pyrogen Tests
10.3.2.4. Monocyte Activity Assay
10.3.3. Consumables
10.3.4. Services
10.3.4.1. Endotoxin Testing Services
10.3.4.2. Monocyte Activation Testing Services
10.4. Market Attractiveness Analysis By Products & Services
11. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Source
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Source, 2024-2031
11.3.1. In-vitro based
11.3.1.1. Whole Blood Based Monocytes
11.3.1.2. Peripheral Blood Mononuclear Cells (PBMC) based Monocytes
11.3.1.3. Cell Line Based Monocytes
11.3.2. Animal Based
11.3.2.1. Recombinant factor C (rFC)
11.3.2.2. Bacterial Endotoxin (BET)
11.3.2.3. Rabbit Pyrogen Tests
11.4. Market Attractiveness Analysis By Source
12. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Source, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
12.3.1. Injectable Therapeutics
12.3.2. Vaccines
12.3.3. Orally Dosed Pharmaceuticals
12.3.4. Biologics
12.3.5. Implantable Medical Devices
12.3.6. Dialysis Liquids
12.3.7. Toxic/immune-modulatory Drugs
12.3.8. Blood-based Product
12.4. Market Attractiveness Analysis By Application
13. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
13.3.1. Pharmaceuticals Companies
13.3.2. Pharmaceuticals Companies
13.3.3. Biotechnology Companies
13.3.4. Medical Device Companies
13.3.5. Diagnostic Laboratories
13.3.6. Clinical Research Organizations(CRO)
13.3.7. Clinical Manufacturing Organizations (CMOs)
13.4. Market Attractiveness Analysis By End User
14. Global Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031, by Region
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2019-2023
14.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2024-2031
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. East Asia
14.3.5. South Asia
14.3.6. Oceania
14.3.7. Middle East and Africa (MEA)
14.4. Market Attractiveness Analysis By Region
15. North America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
15.3.1. By Country
15.3.1.1. U.S.
15.3.1.2. Canada
15.3.2. By Products & Services
15.3.3. By Source
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Latin America Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
16.3.1. By Country
16.3.1.1. Brazil
16.3.1.2. Mexico
16.3.1.3. Rest of Latin America
16.3.2. By Products & Services
16.3.3. By Source
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Europe Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
17.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
17.3.1. By Country
17.3.1.1. Germany
17.3.1.2. Italy
17.3.1.3. France
17.3.1.4. U.K.
17.3.1.5. Spain
17.3.1.6. BENELUX
17.3.1.7. Russia
17.3.1.8. Rest of Europe
17.3.2. By Products & Services
17.3.3. By Source
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. South Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
18.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Thailand
18.3.1.3. Indonesia
18.3.1.4. Malaysia
18.3.1.5. Rest of South Asia
18.3.2. By Products & Services
18.3.3. By Source
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. East Asia Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
19.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
19.3.1. By Country
19.3.1.1. China
19.3.1.2. Japan
19.3.1.3. South Korea
19.3.2. By Products & Services
19.3.3. By Source
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Oceania Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
20.1. Introduction
20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
20.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
20.3.1. By Country
20.3.1.1. Australia
20.3.1.2. New Zealand
20.3.2. By Products & Services
20.3.3. By Source
20.3.4. By Application
20.3.5. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Middle East and Africa Pyrogen Testing Market Analysis 2019-2023 and Forecast 2024-2031
21.1. Introduction
21.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2019-2023
21.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2024-2031
21.3.1. By Country
21.3.1.1. GCC Countries
21.3.1.2. Turkey
21.3.1.3. Northern Africa
21.3.1.4. South Africa
21.3.1.5. Rest of Middle East and Africa
21.3.2. By Products & Services
21.3.3. By Source
21.3.4. By Application
21.3.5. By End User
21.4. Market Attractiveness Analysis
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
22. Country Wise Pyrogen Testing Market Analysis 2024-2031
22.1. Introduction
22.1.1. Market Value Proportion Analysis, By Key Countries
22.1.2. Global Vs. Country Growth Comparison
22.2. U.S. Pyrogen Testing Market Analysis
22.2.1. By Products & Services
22.2.2. By Source
22.2.3. By Application
22.2.4. By End User
22.3. Canada Pyrogen Testing Market Analysis
22.3.1. By Products & Services
22.3.2. By Source
22.3.3. By Application
22.3.4. By End User
22.4. Mexico Pyrogen Testing Market Analysis
22.4.1. By Products & Services
22.4.2. By Source
22.4.3. By Application
22.4.4. By End User
22.5. Brazil Pyrogen Testing Market Analysis
22.5.1. By Products & Services
22.5.2. By Source
22.5.3. By Application
22.5.4. By End User
22.6. Germany Pyrogen Testing Market Analysis
22.6.1. By Products & Services
22.6.2. By Source
22.6.3. By Application
22.6.4. By End User
22.7. Italy Pyrogen Testing Market Analysis
22.7.1. By Products & Services
22.7.2. By Source
22.7.3. By Application
22.7.4. By End User
22.8. France Pyrogen Testing Market Analysis
22.8.1. By Products & Services
22.8.2. By Source
22.8.3. By Application
22.8.4. By End User
22.9. U.K. Pyrogen Testing Market Analysis
22.9.1. By Products & Services
22.9.2. By Source
22.9.3. By Application
22.9.4. By End User
22.10. Spain Pyrogen Testing Market Analysis
22.10.1. By Products & Services
22.10.2. By Source
22.10.3. By Application
22.10.4. By End User
22.11. Russia Pyrogen Testing Market Analysis
22.11.1. By Products & Services
22.11.2. By Source
22.11.3. By Application
22.11.4. By End User
22.12. BENELUX Pyrogen Testing Market Analysis
22.12.1. By Products & Services
22.12.2. By Source
22.12.3. By Application
22.12.4. By End User
22.13. China Pyrogen Testing Market Analysis
22.13.1. By Products & Services
22.13.2. By Source
22.13.3. By Application
22.13.4. By End User
22.14. Japan Pyrogen Testing Market Analysis
22.14.1. By Products & Services
22.14.2. By Source
22.14.3. By Application
22.14.4. By End User
22.15. South Korea Pyrogen Testing Market Analysis
22.15.1. By Products & Services
22.15.2. By Source
22.15.3. By Application
22.15.4. By End User
22.16. India Pyrogen Testing Market Analysis
22.16.1. By Products & Services
22.16.2. By Source
22.16.3. By Application
22.16.4. By End User
22.17. Thailand Pyrogen Testing Market Analysis
22.17.1. By Products & Services
22.17.2. By Source
22.17.3. By Application
22.18. Australia Pyrogen Testing Market Analysis
22.18.1. By Products & Services
22.18.2. By Source
22.18.3. By Application
22.18.4. By End User
22.19. New Zealand Pyrogen Testing Market Analysis
22.19.1. By Products & Services
22.19.2. By Source
22.19.3. By Application
22.19.4. By End User
22.20. GCC Countries Pyrogen Testing Market Analysis
22.20.1. By Products & Services
22.20.2. By Source
22.20.3. By Application
22.20.4. By End User
22.21. Turkey Pyrogen Testing Market Analysis
22.21.1. By Products & Services
22.21.2. By Source
22.21.3. By Application
22.21.4. By End User
22.22. South Africa Pyrogen Testing Market Analysis
22.22.1. By Products & Services
22.22.2. By Source
22.22.3. By Application
22.22.4. By End User
22.23. Indonesia Pyrogen Testing Market Analysis
22.23.1. By Products & Services
22.23.2. By Source
22.23.3. By Application
22.23.4. By End User
22.24. Malaysia Pyrogen Testing Market Analysis
22.24.1. By Products & Services
22.24.2. By Source
22.24.3. By Application
22.24.4. By End User
23. Market Structure Analysis
23.1. Market Analysis by Tier of Companies
23.2. Market Share Analysis of Top Players
23.3. Market Presence Analysis
24. Competition Analysis
24.1. Competition Dashboard
24.2. Competition Benchmarking
24.3. Competition Deep Dive
24.3.1. Thermo Fisher Scientific
24.3.1.1. Overview
24.3.1.2. Product Portfolio
24.3.1.3. Key Financials
24.3.1.4. SWOT Analysis
24.3.1.5. Strategy Overview
24.3.1.5.1. Marketing Strategy
24.3.1.5.2. Channel Strategy
24.3.1.5.3. Product Strategy
24.3.2. Merck KGaA
24.3.2.1. Overview
24.3.2.2. Product Portfolio
24.3.2.3. Key Financials
24.3.2.4. SWOT Analysis
24.3.2.5. Strategy Overview
24.3.2.5.1. Marketing Strategy
24.3.2.5.2. Channel Strategy
24.3.2.5.3. Product Strategy
24.3.3. Lonza
24.3.3.1. Overview
24.3.3.2. Product Portfolio
24.3.3.3. Key Financials
24.3.3.4. SWOT Analysis
24.3.3.5. Strategy Overview
24.3.3.5.1. Marketing Strategy
24.3.3.5.2. Channel Strategy
24.3.3.5.3. Product Strategy
24.3.4. MAT-BioTech
24.3.4.1. Overview
24.3.4.2. Product Portfolio
24.3.4.3. Key Financials
24.3.4.4. SWOT Analysis
24.3.4.5. Strategy Overview
24.3.4.5.1. Marketing Strategy
24.3.4.5.2. Channel Strategy
24.3.4.5.3. Product Strategy
24.3.5. Promega Corporation
24.3.5.1. Overview
24.3.5.2. Product Portfolio
24.3.5.3. Key Financials
24.3.5.4. SWOT Analysis
24.3.5.5. Strategy Overview
24.3.5.5.1. Marketing Strategy
24.3.5.5.2. Channel Strategy
24.3.5.5.3. Product Strategy
24.3.6. GenScript
24.3.6.1. Overview
24.3.6.2. Product Portfolio
24.3.6.3. Key Financials
24.3.6.4. SWOT Analysis
24.3.6.5. Strategy Overview
24.3.6.5.1. Marketing Strategy
24.3.6.5.2. Channel Strategy
24.3.6.5.3. Product Strategy
24.3.7. Associates of Cape Cod, Inc.
24.3.7.1. Overview
24.3.7.2. Product Portfolio
24.3.7.3. Key Financials
24.3.7.4. SWOT Analysis
24.3.7.5. Strategy Overview
24.3.7.5.1. Marketing Strategy
24.3.7.5.2. Channel Strategy
24.3.7.5.3. Product Strategy
24.3.8. BIOMERIEUX SA
24.3.8.1. Overview
24.3.8.2. Product Portfolio
24.3.8.3. Key Financials
24.3.8.4. SWOT Analysis
24.3.8.5. Strategy Overview
24.3.8.5.1. Marketing Strategy
24.3.8.5.2. Channel Strategy
24.3.8.5.3. Product Strategy
24.3.9. Ella A/S
24.3.9.1. Overview
24.3.9.2. Product Portfolio
24.3.9.3. Key Financials
24.3.9.4. SWOT Analysis
24.3.9.5. Strategy Overview
24.3.9.5.1. Marketing Strategy
24.3.9.5.2. Channel Strategy
24.3.9.5.3. Product Strategy
24.3.10. Hycult Biotech Inc.
24.3.10.1. Overview
24.3.10.2. Product Portfolio
24.3.10.3. Key Financials
24.3.10.4. SWOT Analysis
24.3.10.5. Strategy Overview
24.3.10.5.1. Marketing Strategy
24.3.10.5.2. Channel Strategy
24.3.10.5.3. Product Strategy
24.3.11. Eurofins Biolab Srl
24.3.11.1. Overview
24.3.11.2. Product Portfolio
24.3.11.3. Key Financials
24.3.11.4. SWOT Analysis
24.3.11.5. Strategy Overview
24.3.11.5.1. Marketing Strategy
24.3.11.5.2. Channel Strategy
24.3.11.5.3. Product Strategy
24.3.12. Solvias AG
24.3.12.1. Overview
24.3.12.2. Product Portfolio
24.3.12.3. Key Financials
24.3.12.4. SWOT Analysis
24.3.12.5. Strategy Overview
24.3.12.5.1. Marketing Strategy
24.3.12.5.2. Channel Strategy
24.3.12.5.3. Product Strategy
24.3.13. Wickham Laboratories Ltd.
24.3.13.1. Overview
24.3.13.2. Product Portfolio
24.3.13.3. Key Financials
24.3.13.4. SWOT Analysis
24.3.13.5. Strategy Overview
24.3.13.5.1. Marketing Strategy
24.3.13.5.2. Channel Strategy
24.3.13.5.3. Product Strategy
24.3.14. Sotera Health (Nelson Laboratories, LLC)
24.3.14.1. Overview
24.3.14.2. Product Portfolio
24.3.14.3. Key Financials
24.3.14.4. SWOT Analysis
24.3.14.5. Strategy Overview
24.3.14.5.1. Marketing Strategy
24.3.14.5.2. Channel Strategy
24.3.14.5.3. Product Strategy
24.3.15. Charles River Laboratories
24.3.15.1. Overview
24.3.15.2. Product Portfolio
24.3.15.3. Key Financials
24.3.15.4. SWOT Analysis
24.3.15.5. Strategy Overview
24.3.15.5.1. Marketing Strategy
24.3.15.5.2. Channel Strategy
24.3.15.5.3. Product Strategy
24.3.16. Creative Biolabs
24.3.16.1. Overview
24.3.16.2. Product Portfolio
24.3.16.3. Key Financials
24.3.16.4. SWOT Analysis
24.3.16.5. Strategy Overview
24.3.16.5.1. Marketing Strategy
24.3.16.5.2. Channel Strategy
24.3.16.5.3. Product Strategy
24.3.17. Sanquin Reagents B.V.
24.3.17.1. Overview
24.3.17.2. Product Portfolio
24.3.17.3. Key Financials
24.3.17.4. SWOT Analysis
24.3.17.5. Strategy Overview
24.3.17.5.1. Marketing Strategy
24.3.17.5.2. Channel Strategy
24.3.17.5.3. Product Strategy
24.3.18. Fujifilm Wako Pure Chemical Corporation
24.3.18.1. Overview
24.3.18.2. Product Portfolio
24.3.18.3. Key Financials
24.3.18.4. SWOT Analysis
24.3.18.5. Strategy Overview
24.3.18.5.1. Marketing Strategy
24.3.18.5.2. Channel Strategy
24.3.18.5.3. Product Strategy
24.3.19. MAT Research
24.3.19.1. Overview
24.3.19.2. Product Portfolio
24.3.19.3. Key Financials
24.3.19.4. SWOT Analysis
24.3.19.5. Strategy Overview
24.3.19.5.1. Marketing Strategy
24.3.19.5.2. Channel Strategy
24.3.19.5.3. Product Strategy
24.3.20. Xiamen Bioendo Technology Co. Ltd.
24.3.20.1. Overview
24.3.20.2. Product Portfolio
24.3.20.3. Key Financials
24.3.20.4. SWOT Analysis
24.3.20.5. Strategy Overview
24.3.20.5.1. Marketing Strategy
24.3.20.5.2. Channel Strategy
24.3.20.5.3. Product Strategy
24.3.21. Microcoat Biotechnologie GmbH
24.3.21.1. Overview
24.3.21.2. Product Portfolio
24.3.21.3. Key Financials
24.3.21.4. SWOT Analysis
24.3.21.5. Strategy Overview
24.3.21.5.1. Marketing Strategy
24.3.21.5.2. Channel Strategy
24.3.21.5.3. Product Strategy
24.3.22. PerkinElmer Inc.
24.3.22.1. Overview
24.3.22.2. Product Portfolio
24.3.22.3. Key Financials
24.3.22.4. SWOT Analysis
24.3.22.5. Strategy Overview
24.3.22.5.1. Marketing Strategy
24.3.22.5.2. Channel Strategy
24.3.22.5.3. Product Strategy
24.3.23. Orchid Scientific & Innovative Pvt Ltd.
24.3.23.1. Overview
24.3.23.2. Product Portfolio
24.3.23.3. Key Financials
24.3.23.4. SWOT Analysis
24.3.23.5. Strategy Overview
24.3.23.5.1. Marketing Strategy
24.3.23.5.2. Channel Strategy
24.3.23.5.3. Product Strategy
25. Assumptions and Acronyms Used
26. Research Methodology
°ü·ÃÀÚ·á